<?xml version="1.0" encoding="UTF-8"?>
<billStatus>
  <bill>
    <notes />
    <title>Pharmaceutical Information Exchange Act</title>
    <committees>
      <billCommittees>
        <item>
          <activities>
            <item>
              <name>Referred to</name>
              <date>2017-04-06T13:16:10Z</date>
            </item>
          </activities>
          <chamber>House</chamber>
          <systemCode>hsif00</systemCode>
          <name>Energy and Commerce Committee</name>
          <type>Standing</type>
          <subcommittees>
            <item>
              <systemCode>hsif14</systemCode>
              <activities>
                <item>
                  <name>Reported by</name>
                  <date>2018-01-17T17:50:24Z</date>
                </item>
                <item>
                  <name>Markup by</name>
                  <date>2018-01-17T17:49:21Z</date>
                </item>
                <item>
                  <name>Referred to</name>
                  <date>2017-04-07T14:49:38Z</date>
                </item>
              </activities>
              <name>Health Subcommittee</name>
            </item>
          </subcommittees>
        </item>
      </billCommittees>
    </committees>
    <committeeReports />
    <cboCostEstimates />
    <congress>115</congress>
    <laws />
    <updateDate>2018-08-28T20:05:33Z</updateDate>
    <relatedBills />
    <version>1.0.0</version>
    <actions>
      <item>
        <actionDate>2018-01-17</actionDate>
        <committee>
          <systemCode>hsif14</systemCode>
          <name>Health Subcommittee</name>
        </committee>
        <links />
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Forwarded by Subcommittee to Full Committee (Amended) by the Yeas and Nays: 18 - 14 .</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2018-01-17</actionDate>
        <committee>
          <systemCode>hsif14</systemCode>
          <name>Health Subcommittee</name>
        </committee>
        <links />
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Subcommittee Consideration and Mark-up Session Held.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2017-04-07</actionDate>
        <committee>
          <systemCode>hsif14</systemCode>
          <name>Health Subcommittee</name>
        </committee>
        <links />
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Referred to the Subcommittee on Health.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2017-04-06</actionDate>
        <actionCode>H11100</actionCode>
        <text>Referred to the House Committee on Energy and Commerce.</text>
        <committee>
          <systemCode>hsif00</systemCode>
          <name>Energy and Commerce Committee</name>
        </committee>
        <links />
        <type>IntroReferral</type>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2017-04-06</actionDate>
        <actionCode>Intro-H</actionCode>
        <text>Introduced in House</text>
        <committee />
        <links />
        <type>IntroReferral</type>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2017-04-06</actionDate>
        <actionCode>1000</actionCode>
        <text>Introduced in House</text>
        <committee />
        <links />
        <type>IntroReferral</type>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <actionTypeCounts>
        <placeholderTextForH>2</placeholderTextForH>
        <designationOfSpeakerProTempore>1</designationOfSpeakerProTempore>
        <billReferrals>1</billReferrals>
        <introducedInHouse>1</introducedInHouse>
        <introducedInTheHouse>1</introducedInTheHouse>
      </actionTypeCounts>
      <actionByCounts>
        <houseOfRepresentatives>6</houseOfRepresentatives>
      </actionByCounts>
    </actions>
    <sponsors>
      <item>
        <fullName>Rep. Guthrie, Brett [R-KY-2]</fullName>
        <identifiers>
          <bioguideId>G000558</bioguideId>
          <lisID>1922</lisID>
          <gpoId>7954</gpoId>
        </identifiers>
        <bioguideId>G000558</bioguideId>
        <lastName>Guthrie</lastName>
        <firstName>Brett</firstName>
        <party>R</party>
        <byRequestType />
        <middleName />
        <state>KY</state>
        <district>2</district>
      </item>
    </sponsors>
    <billType>HR</billType>
    <constitutionalAuthorityStatementText><![CDATA[<pre>[Congressional Record Volume 163, Number 60 (Thursday, April 6, 2017)]From the Congressional Record Online through the Government Publishing Office [<a href='http://www.gpo.gov'>www.gpo.gov</a>]By Mr. GUTHRIE:H.R. 2026.Congress has the power to enact this legislation pursuantto the following:Article 1 Section 8 of the United States Constitution[Page H2791]</pre>]]></constitutionalAuthorityStatementText>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <recordedVotes />
    <billNumber>2026</billNumber>
    <titles>
      <item>
        <chamberCode />
        <titleType>Short Titles as Introduced</titleType>
        <chamberName />
        <title>Pharmaceutical Information Exchange Act</title>
        <parentTitleType />
      </item>
      <item>
        <chamberCode />
        <titleType>Official Title as Introduced</titleType>
        <chamberName />
        <title>To improve patient access to emerging medication therapies by clarifying the scope of permitted health care economic and scientific information communications between biopharmaceutical manufacturers and population health decision makers.</title>
        <parentTitleType />
      </item>
      <item>
        <chamberCode />
        <titleType>Display Title</titleType>
        <chamberName />
        <title>Pharmaceutical Information Exchange Act</title>
        <parentTitleType />
      </item>
      <item>
        <chamberCode />
        <titleType>(Extracted from GPO) Short Titles as Introduced</titleType>
        <chamberName />
        <title>Pharmaceutical Information Exchange Act</title>
        <parentTitleType />
      </item>
    </titles>
    <originChamber>House</originChamber>
    <subjects>
      <billSubjects>
        <policyArea>
          <name>Health</name>
        </policyArea>
        <legislativeSubjects>
          <item>
            <name>Drug safety, medical device, and laboratory regulation</name>
          </item>
          <item>
            <name>Fraud offenses and financial crimes</name>
          </item>
          <item>
            <name>Health information and medical records</name>
          </item>
          <item>
            <name>Medical research</name>
          </item>
        </legislativeSubjects>
      </billSubjects>
    </subjects>
    <cosponsors />
    <introducedDate>2017-04-06</introducedDate>
    <calendarNumbers />
    <latestAction>
      <actionDate>2018-01-17</actionDate>
      <links />
      <text>Forwarded by Subcommittee to Full Committee (Amended) by the Yeas and Nays: 18 - 14 .</text>
    </latestAction>
    <amendments />
    <summaries>
      <billSummaries>
        <item>
          <lastSummaryUpdateDate>2017-12-19T22:45:26Z</lastSummaryUpdateDate>
          <actionDate>2017-04-06</actionDate>
          <text><![CDATA[<p><strong>Pharmaceutical Information Exchange Act</strong></p> <p>This bill amends the Federal Food, Drug, and Cosmetic Act to&nbsp;allow information about&nbsp;a new&nbsp;investigational medication or the investigational use of a medication&nbsp;approved&nbsp;by the Food and Drug Administration&nbsp;to be provided to health care entities if the information is based on reliable scientific evidence.</p>]]></text>
          <updateDate>2017-04-06T04:00:00Z</updateDate>
          <name>Introduced in House</name>
          <versionCode>00</versionCode>
          <actionDesc>Introduced in House</actionDesc>
        </item>
      </billSummaries>
    </summaries>
    <createDate>2017-04-07T03:11:59Z</createDate>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>

